Semi-Annual Statement Of Income And Retained Earnings

OncoTherapy Science, Inc. - Filing #7604688

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-1,684,530,000 JPY
-368,107,000 JPY
-2,052,637,000 JPY
-1,635,896,000 JPY
-48,633,000 JPY
-2,016,649,000 JPY
-1,368,439,000 JPY
-1,423,865,000 JPY
-1,130,736,000 JPY
-293,129,000 JPY
-214,070,000 JPY
-1,637,936,000 JPY
Non-operating income
Non-operating income
1,041,000 JPY
24,843,000 JPY
35,419,000 JPY
2,385,000 JPY
Non-operating expenses
Non-operating expenses
20,187,000 JPY
19,544,000 JPY
3,641,000 JPY
3,711,000 JPY
Ordinary profit (loss)
-2,071,783,000 JPY
-2,011,350,000 JPY
-1,336,660,000 JPY
-1,639,262,000 JPY
Extraordinary income
Extraordinary income
49,250,000 JPY
49,201,000 JPY
90,022,000 JPY
90,071,000 JPY
Extraordinary losses
Extraordinary losses
547,773,000 JPY
464,088,000 JPY
300,000,000 JPY
10,821,000 JPY
Profit (loss) before income taxes
-2,570,306,000 JPY
-2,426,236,000 JPY
-1,546,637,000 JPY
-1,560,012,000 JPY
Income taxes - current
2,896,000 JPY
1,656,000 JPY
1,656,000 JPY
2,896,000 JPY
Income taxes - deferred
-1,662,000 JPY
-1,662,000 JPY
-1,273,000 JPY
-1,273,000 JPY
Profit (loss)
-2,426,231,000 JPY
-2,426,231,000 JPY
-2,426,231,000 JPY
-2,571,541,000 JPY
-2,426,231,000 JPY
-1,547,021,000 JPY
-1,547,021,000 JPY
-1,547,021,000 JPY
-1,561,636,000 JPY
-1,547,021,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.